SCHEMBL20550326

SCHEMBL20550326

CCCCc1ccc(-c2nc(C)c(-c3ccnc(-c4cccnc4)n3)s2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
LMNA P02545 3/20 0.47
HTT P42858 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
KCNH2 Q12809 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
CLK4 Q9HAZ1 4/20 0.43
PPARA Q07869 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 1/20 0.40
COMT P21964 1/20 0.40
CYP3A4 P08684 4/20 0.39
CYP2C19 P33261 4/20 0.39
CYP2D6 P10635 3/20 0.39
CYP19A1 P11511 1/20 0.39
CYP2C9 P11712 1/20 0.39
TRPV1 Q8NER1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20550694 0.82 ALDH1A1 (0.52) ALDH1A1LMNAHTTNPSR1KCNH2
SCHEMBL20550293 0.80 CDK4 (0.54) ALDH1A1LMNACLK4SMN1; SMN2NPC1
SCHEMBL20550274 0.80 COMT (0.41) ALDH1A1LMNANPSR1KCNH2HRH3
SCHEMBL1679855 0.80 CYP3A4 (0.49) ALDH1A1LMNAHTTNPSR1KCNH2
SCHEMBL20550291 0.79 CDK2 (0.46) COMT
SCHEMBL12279254 0.78 KCNH2 (0.41) ALDH1A1LMNAHTTNPSR1KCNH2
SCHEMBL20550693 0.78 KDM4E (0.40) ALDH1A1LMNANPSR1SMN1; SMN2NPC1
SCHEMBL20550428 0.78 CDK2 (0.41) RAB9AKDM4ECOMTL3MBTL1
SCHEMBL12278345 0.77 CYP3A4 (0.46) ALDH1A1LMNAHTTNPSR1KCNH2
SCHEMBL20550442 0.77 COMT (0.39) ALDH1A1LMNAPPARASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10414759-B2 Phenylthiazoles and uses thereof PURDUE RESEARCH FOUNDATION (US) 2019-09-17 US disclosed
US-20180319784-A1 PHENYLTHIAZOLES AND USES THEREOF PURDUE RESEARCH FOUNDATION (US) 2018-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180319784-A1 PHENYLTHIAZOLES AND USES THEREOF TPMT, TST, CLPP ALDH1A1 2016/4885LMNA 4725/4885HTT 2765/4885
US-10414759-B2 Phenylthiazoles and uses thereof TPMT, TST, CLPP ALDH1A1 1901/4885LMNA 4733/4885HTT 3052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.